Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Marcove

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
National Cancer Institute Monograph|April 1, 1981
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)G Rosen, A Nirenberg, B Caparros, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapyG Rosen, R C Marcove, A G Huvos, et al.
Cancer Investigation|January 1, 1984
Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumorsG Rosen, B Caparros, S Groshen, et al.
Cancer|May 1, 1981
Ewing's sarcoma: ten-year experience with adjuvant chemotherapyG Rosen, B Caparros, A Nirenberg, et al.
Medical and Pediatric Oncology|January 1, 1992
Primary skeletal non-Hodgkin's lymphoma in the pediatric age groupN Wollner, J M Lane, R C Marcove, et al.
Cancer|March 15, 1982
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyG Rosen, B Caparros, A G Huvos, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
National Cancer Institute Monograph|April 1, 1981
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)G Rosen, A Nirenberg, B Caparros, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapyG Rosen, R C Marcove, A G Huvos, et al.
Cancer Investigation|January 1, 1984
Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumorsG Rosen, B Caparros, S Groshen, et al.
Cancer|May 1, 1981
Ewing's sarcoma: ten-year experience with adjuvant chemotherapyG Rosen, B Caparros, A Nirenberg, et al.
Medical and Pediatric Oncology|January 1, 1992
Primary skeletal non-Hodgkin's lymphoma in the pediatric age groupN Wollner, J M Lane, R C Marcove, et al.
Cancer|March 15, 1982
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyG Rosen, B Caparros, A G Huvos, et al.
Pageof 11